Furthermore, DU‐145 prostate cancer cells treated with c‐Myc inhibitors at a concentration of 25 μM exhibited a significant decrease in cell viability, with all compounds causing reductions of at least 60%. This evidence concerns the gene MYC and prostate cancer.